Literature DB >> 10367949

Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose.

J Wiström1, C Ahlm, S Lundberg, B Settergren, A Tärnvik.   

Abstract

We here studied the antibody response to a booster dose four years after the administration of one single dose of recombinant HB vaccine. Before receiving the booster dose, levels of protective antibodies (anti-HBs) were generally low and 24/41 (59%) individuals lacked detectable antibodies (< 1 IU/L). Within 14 d of booster vaccination, 36/38 (95%) vaccinees showed levels of antibodies > 100 IU/L. Notably, these levels were at least as high as those of a reference group 12 months after initiation of vaccination according to the standard three-dose vaccination at intervals of 0, 1 and 6 months. In conclusion, one single dose of HB vaccine seemed to confer on young healthy individuals a well preserved B cell memory, disclosed as a rapid and strong antibody response to a second dose four years later.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367949     DOI: 10.1016/s0264-410x(99)00012-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination.

Authors:  Ru-Xiang Wang; Greet J Boland; Jan van Hattum; Gijsbert C de Gast
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

Review 2.  Raising expectations for subunit vaccine.

Authors:  John T Schiller; Douglas R Lowy
Journal:  J Infect Dis       Date:  2014-11-24       Impact factor: 5.226

3.  Prevention of Viral Hepatitis.

Authors:  Raymond S. Koff
Journal:  Curr Treat Options Gastroenterol       Date:  2002-12

Review 4.  Unsolved problems and future perspectives of hepatitis B virus vaccination.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

5.  Hepatitis B vaccination among a national sample of gay and bisexual men.

Authors:  Paul L Reiter; Noel T Brewer
Journal:  Sex Transm Dis       Date:  2011-03       Impact factor: 2.830

6.  Preclinical evaluation of a two-dose vaccination schedule of recombinant Hansenula polymorpha hepatitis B vaccine in animals.

Authors:  Jin Li; Deyou Zhang; Rui Ma; Xuqin Yang; Xi Wang; Caimei Li; Sucai Zhang; Hesheng Xue; Kai Zhao; Hui Zhuang
Journal:  Hum Vaccin Immunother       Date:  2013-01-31       Impact factor: 3.452

Review 7.  Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

Authors:  Gillian M Keating; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Persistence of HBV Vaccine's Protection and Response to Hepatitis B Booster Immunization in 5- to 7-Year-Old Children in the Kohgiloyeh and Boyerahmad Province, Iran.

Authors:  Behrouz Yazdanpanah; Mitra Safari; Shahrzad Yazdanpanah
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660

9.  Levamizole enhances immune responsiveness to intra-dermal and intra-muscular hepatitis B vaccination in chronic hemodialysis patients.

Authors:  Hassan Argani; Ebrahim Akhtarishojaie
Journal:  J Immune Based Ther Vaccines       Date:  2006-05-30

Review 10.  Hepatitis A, hepatitis B, and combination hepatitis vaccines for immunoprophylaxis: an update.

Authors:  Raymond S Koff
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.